Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yabang Johnson Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of the Jiangsu Yabang Pharmaceutical Group. Based in Changzhou, the company specializes in the research, development, and large-scale manufacturing of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio spans several therapeutic areas, including cardiovascular, digestive, and anti-infective treatments, with notable products such as amlodipine besylate and omeprazole. The company operates state-of-the-art GMP-certified facilities and maintains a significant presence in both domestic and international markets, focusing on high-quality generic drug production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Yabang Johnson Pharmaceutical.